News From Terre Haute, Indiana

Local & Bistate

Related Photos

  • Tribune-Star/Jim Avelis Cutting edge: Leading cancer scientist Bruce Horten spoke about his cutting edge techniques of engineering new cancer treatments in a presentation last night at Rose-Hulman's Hatfield Hall Theater. Horten is the National Medical Director for the Integrated Oncology Laboratory with LabCorp.

    MET112912horten.jpg

Discussion

Welcome to our online comments feature. We welcome your thoughts and your opinions, including unpopular ones. We ask only that you keep the conversation civil and clean. We reserve the right to remove comments that are obscene, racist or abusive and statements that are false or unverifiable as well as posts that are attacking other users. Repeat offenders will be blocked. You may flag objectionable comments for review by a moderator.
comments powered by Disqus
November 30, 2012

Rose-Hulman speaker on medicine’s cutting edge

Brian Boyce The Tribune-Star

TERRE HAUTE — The answers needed to solve medicine’s biggest puzzles might well be found in the puzzles’ smallest parts.

The theater in Hatfield Hall was full Thursday evening as Rose-Hulman Institute of Technology hosted one of the country’s leading cancer scientists for a discussion concerning targeted therapy. Bruce Horten, M.D., National Medical Director for the Integrated Oncology Laboratory at LabCorp, explained to engineering students and professors alike the rapidly growing opportunities possible through merging science and technology.

Prior to his speech, Horten explained the relatively new concept of targeted therapy as it differs from treatments such as chemotherapy or surgery.

“At this stage, we are in the infancy of targeted therapy,” he said, noting the crucial role engineers can play in advancing this approach.

In broad terms, targeted therapy seeks to address cancer at its source, working with biological molecules as small as nucleotides, which form the building blocks of nucleic acids through units of three, called codons. These blocks ultimately become a protein, but the structure it assumes is determined by genes. One flaw in one gene could result in a misshapen protein, and perhaps even cancer.

“The targets we’re looking for are incredibly small, tiny,” he said, explaining the work with nucleotides themselves.

But by tailoring medicine to address structures at that level, the dysfunction they cause can be arrested without destroying healthy tissue, he said.

“There are advantages to using targeted therapy as opposed to chemotherapy,” he remarked, explaining that with the latter, a toxic agent is spread throughout the entire body. The hope is that the medicine will be less toxic to healthy cells than to the cancer, but inevitably many of the former are killed. Targeted drugs are much milder on the body, he noted.

In the case of chronic myelogenous leukemia, or CML, such medicine has been demonstrated to convert a once deadly disease into a chronic condition. The drug marketed as “Gleevec” has been in use since 2001 on such patients, and has been shown to arrest the disease, he said. As long as patients use the drug, the disease is held at bay. But if the drug is removed, the disease resumes its spread, he explained.

“Well, that’s just phenomenal,” he said, remarking this makes for a significant change considering that disease was once terminal.

But that particular drug is effective by controlling just one gene. What happens when battling a type of cancer requires a drug that can simultaneously hit 15 targets, he posed. The problem with targeted therapy at present is that cancer is a dynamic condition and multiple genes are at play, all interacting one with the others. Going forward, researchers are working on “multi-targeted” drugs, but the technology required to study those dynamics at the molecular level is limited, he said.

Hence medicine’s outreach to the engineering world.

Horten’s speech was the first in a series to be hosted at Rose-Hulman, all of which will aim to address what the National Academy of Engineering has termed the eight Grand Challenges of Engineering, medicine being one. Funded by Christa Percopo, wife of the late Rose-Hulman graduate and board member Michael, the series is hoped to offer engineering students a chance to see where their work might take them.

Rose-Hulman president Robert Coons credited Percopo’s gifts as important in helping foster discussions which span the bridge between academic and pragmatic.

“Unfortunately, cancer has probably touched the lives of many of here tonight,” he said in his introductory remarks.

Horten pointed out that for many in medicine, the side effects and limitations of drugs are simply a matter of reality. But for engineering students such as those at Rose-Hulman, they offer a puzzle to be solved.

Dr. Ross Weatherman of Rose-Hulman’s chemistry department brought along student Katherine Moravec for Thursday evening’s presentation. His class is studying targeted therapy in light of estrogen receptor proteins in breast cancer therapy, focusing on the drug Tamoxifen.

“It’s a pretty common breast cancer drug,” he said, explaining his group is working to replicate, and test its replicas.

Eventually, cancers tend to become resistant to the drugs used in targeted therapy, he said. But through further study, methods to keep it bay can be found. Discussions such as those fostered Thursday evening help students see where their work can make a real difference in application, he said.

Brian Boyce can be reached at 812-231-4253 or brian.boyce@tribstar.com.

Text Only | Photo Reprints
Local & Bistate
Latest News
Community Calendar
Loading…
Events by eviesays.com
TribStar.com Poll
AP Video
Conn. Commuter Trains Collide; 60 Go to Hospital Coffee Run Leads to Hatchet Hitchhiker Arrest Fmr. IRS Head Insists No Politics in Targeting Lotto Fever Sweeps the Country Raw: Driver Ejected From Truck, Over Bridge CDC: Fecal Bacteria Common in Swimming Pools Horse Saved From Slaughter, Goes on to Win Big Dying Man's Blinks Lead to Murder Conviction Terror Suspect Due in Court in Idaho Friday Raw: Germany Protestors Picket Barbie House China, Others Want What's Under the Arctic Ice Raw: Crash Sends Car Into Fla. Pool Raw: Obama Sits Down With Elementary Kids Raw: 6 Die in Russian Ship Fire NM Mom Chases Down Child Abductor Officials Arrest Man in Idaho in Terrorism Case Raw: Child, Stroller Falls Onto Pa. Train Tracks Jolie Genetic Cancer Risk High but Rare ShowBiz Minute: Jolie, Jackson, 24 Raw: School Bus Crash Injures Five Children
NDN Video
Lotto Fever Sweeps the Country Coffee Stop Leads To Arrest Of YouTube Sensation Wanted For Murder Bearded Dragon Reunited With Owner Marine Reunited with Warzone Companion Raw: Crash Sends Car Into Fla. Pool Beyonce Is Pregnant! SF baseball player overpaid $500,000 RETURNS money -- and team says KEEP IT $1 Million in Jewels Stolen at Cannes Film Fest Dad returns from Afghanistan, surprises family during Rays' first pitch See Jennifer Lopez's New $10m Hamptons Mansion Woman tricked into taking abortion pill Emma Watson Goes Pantless IRS scandal: Republicans seek to tie Obama to agency's woes Play of the Day: Flipping to Safety Pregnant Kim Kardashian Squeezes Her Swollen Feet Into Stilettos Top Videos of the Week: Angry Taco Bell Guy, Glacier Moves on House, Dog Hates Baths Cindy Crawford Stuns At Cannes Raw: Marines Come to Obama's Aid in the Rain CUTE: Monkey shares lollipop with dog, then HITS pooch on head with it Miranda Kerr Looks Sexy in a Bikini Photo Shoot
Parade
Magazine
Click HERE to read all your Parade favorites including Hollywood Wire, Celebrity interviews and photo galleries, Food recipes and cooking tips, Games and lots more.
  • -

     

    March 12, 2010

activity
Real Estate News